In 1989, after more than a decade of work, a Croatian researcher named Predrag Sikiri isolated a molecule he believed was that protector, and named it BPC-157 [1][2]
Taken as coffee or tea it arrives with polyphenols, the chlorogenic acids in coffee and the catechins in tea, and both beverages are linked to lower all-cause mortality in large cohort studies, which sets the drink apart from a caffeine pill
Use only for immediate consumption
BPC-157 does not simply mask symptoms or temporarily reduce inflammation
Nitric-oxide (NO), VEGF/VEGFR2, and FAK-paxillin pathway activity in cell-culture models of soft-tissue repair using BPC-157
Daily habits dictate baseline oxidative load